| 中文名称: | Cardiogenol C HCL | ||||
|---|---|---|---|---|---|
| 英文名称: | Cardiogenol C HCL | ||||
| 别名: | Wnt 4-(2-Hydroxyethylamino)-2-(4-methoxyphenylamino)-pyrimidine hydrochloride | ||||
| CAS No: | 671225-39-1 | 分子式: | C13H16N4O2.HCl | 分子量: | 296.75 |
| CAS No: | 671225-39-1 | ||||
| 分子式: | C13H16N4O2.HCl | ||||
| 分子量: | 296.75 | ||||
基本信息
|
产品编号： |
C10392 |
||||
|
产品名称： |
Cardiogenol C HCL |
||||
|
CAS: |
671225-39-1 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
|
||||
|
分子式： |
溶于液体 |
-80℃ |
两年 |
||
|
分子量 |
296.75 |
-20℃ |
1个月 |
||
|
化学名： |
4-(2-Hydroxyethylamino)-2-(4-methoxyphenylamino)-pyrimidine hydrochloride |
||||
|
Solubility (25°C)： |
|||||
|
体外:
|
DMSO |
≥ 55mg/mL (185.34mM) |
|||
|
Water |
2 mg/mL (6.74mM; Need ultrasonic) |
||||
|
Ethanol |
|
||||
|
体内(现配现用): |
1.请依序添加每种溶剂： 10% DMSO→40% PEG300→5% Tween-80→45% saline Solubility: 2.5 mg/mL (8.42mM); Clear solution; Need ultrasonic |
||||
|
此方案可获得 2.5 mg/mL (8.42mM) 的澄清溶液。 以 1mL 工作液为例，取 100μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400μL PEG300 中，混合均匀；向上述体系中加入50μL Tween-80，混合均匀；然后继续加入 450μL生理盐水定容至 1mL。 |
|||||
|
2.请依序添加每种溶剂： 10% DMSO→90% (20% SBE-β-CD in saline) Solubility: ≥ 2.5 mg/mL (8.42mM); Clear solution |
|||||
|
此方案可获得 ≥ 2.5 mg/mL (8.42mM，饱和度未知) 的澄清溶液。 以 1mL 工作液为例，取 100μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900μL 20% 的 SBE-β-CD 生理盐水水溶液中，混合均匀。 |
|||||
|
3.请依序添加每种溶剂： 10% DMSO→90% corn oil Solubility: ≥ 2.5 mg/mL (8.42mM); Clear solution |
|||||
|
此方案可获得 ≥ 2.5 mg/mL (8.42mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。 以 1mL 工作液为例，取 100μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900μL玉米油中，混合均匀。 |
|||||
|
＜1mg/ml表示微溶或不溶。 |
|||||
|
普西唐提供的所有化合物浓度为内部测试所得，实际溶液度可能与公布值有所偏差，属于正常的批间细微差异现象。 |
|||||
|
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；⼀旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 |
|||||
制备储备液
|
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
|
1mM |
3.3698mL |
16.8492mL |
33.6984mL |
|
5mM |
0.6740mL |
3.3698mL |
6.7397mL |
|
10mM |
0.3370mL |
1.6849mL |
3.3698mL |
生物活性
|
产品描述 |
一种二氨基嘧啶化合物，可诱导MHC阳性心肌细胞与胚胎干细胞分化，EC50:0.1μM。 |
|
|
靶点 |
EC50: 100nM (differentiation of ESCs into cardiomyocytes) |
|
|
体外研究 |
Cardiogenol C hydrochloride (1μM; 7 days) has a cardiomyogenic effect on P19 cells, it significantly increases atrial natriuretic factor (ANF, nppa) in P19 cells when it compares to untreated control cells. Cardiogenol C hydrochloride (0.01-100μM; 7 days) significantly increases ANF expression. In addition, another frequently used cardiac marker gene (NKX2-5) is also significantly increased by this small molecule in C2C12 cells. Cardiogenol C hydrochloride (0.001-100μM; 7 days) increases cardiac Nav1.5 sodium channel protein expression as dosedependent manner in C2C12 cells. Cardiogenol C hydrochloride (1μM; 35 days) addition from day 0 significantly increases myocardial differentiation and results in a significantly increased percentage of CBs with beating cardiomyocytes. This small moleculepromotes the development of beating cardiomyocytes in cardiovascular progenitor cell-derived cardiac bodies . Cardiogenol C hydrochloride (0.01-100μM; 7 days) does not effect cell growth even at 10μM. In addition, Cardiogenol C either solves in water or DMSO generates a similar effect. The highest concentration, 100μM has significant cellular toxicity on C2C12 cells. RT-PCR |
|
|
Cell Line: |
C2C12 cells |
|
|
Concentration: |
0.01μM; 0.1μM; 1μM; 3μM; 10μM; 30μM; 100μM |
|
|
Incubation Time: |
7 days |
|
|
Result: |
Increased ANF and NKX2.5 mRNA level as a dose-dependent manner. |
|
|
Western Blot Analysis |
||
|
Cell Line: |
C2C12 cells |
|
|
Concentration: |
0.001μM; 0.01μM; 0.1μM; 1μM; 10μM |
|
|
Incubation Time: |
7 days |
|
|
Result: |
Increased cardiac Nav1.5 sodium channel protein levels. |
|
|
Cell Proliferation Assay |
||
|
Cell Line: |
C2C12 cells |
|
|
Concentration: |
0.01μM; 0.1μM; 1μM |
|
|
Incubation Time: |
7 days |
|
|
Result: |
Did not exert toxic effects on C2C12 cells at 0.01-10μM treatment. |
|
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系，公式为：
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液，使用的计算公式为：
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为：C1V1 = C2V2 ( 输入 输出 )
